Stay updated on Seribantumab in NRG1 Gene Fusion Clinical Trial
Sign up to get notified when there's something new on the Seribantumab in NRG1 Gene Fusion Clinical Trial page.

Latest updates to the Seribantumab in NRG1 Gene Fusion Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe study of Seribantumab in adult patients with NRG1 gene fusion positive advanced solid tumors has been updated, with results now posted and the revision number changed to v2.14.4.SummaryDifference2%
- Check66 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.5%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to Seribantumab in NRG1 Gene Fusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seribantumab in NRG1 Gene Fusion Clinical Trial page.